Evidence map›Paper›PMID 33789461›Full record

ArticlePsychiatric services (Washington, D.C.)2021

Health Care Utilization Due to Substance Abuse Among Homeless and Nonhomeless Children and Young Adults in New York.

Rie Sakai-Bizmark, Eliza J Webber, Dennys Estevez, Mary Murillo, Emily H Marr, Lauren E M Bedel, Laurie A Mena, Jayde Clarice D Felix, Lynne M Smith

Open access · greenAbstract read
In one paragraph

Article in Psychiatric services (Washington, D.C.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rie Sakai-BizmarkThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Eliza J WebberThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Dennys EstevezThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Mary MurilloThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Emily H MarrThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Lauren E M BedelThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Laurie A MenaThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Jayde Clarice D FelixThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
Lynne M SmithThe Lundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California (all authors); Department of Pediatrics, David Geffen School of Medicine, Harbor-UCLA Medical Center, Torrance, California (Sakai-Bizmark, Smith).
UCLA Medical Center · US

Funding

Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementationK01HL141697 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SAKAI-BIZMARK, RIE · 2018 to 2022
$688k
NHLBI NIH HHS K01 HL141697
6 · The paper itself

Abstract

objectiveSubstance abuse, particularly among homeless youths, is a significant public health challenge in the United States. Detailed data about health care utilization resulting from this preventable behavior remain sparse. This study aimed to compare health care utilization rates related to substance abuse among homeless and nonhomeless youths.

methodsA secondary data analysis evaluated records of homeless and nonhomeless patients under age 25 with a primary diagnosis of substance abuse, identified in 2013 and 2014 New York Statewide Inpatient and Emergency Department (ED) Databases. Outcomes included ED visit rate, hospitalization rate, in-hospital mortality, cost, length of stay (LOS), intensive care unit (ICU) utilization, and revisit or readmission rate. Multivariable regression models with a year fixed effect and facility random effect were used to evaluate the association between homelessness and each outcome.

resultsA total of 68,867 cases included hospitalization or an ED visit related to substance abuse (68,118 nonhomeless and 749 homeless cases). Rates of ED visits related to substance abuse were 9.38 and 4.96, while rates of hospitalizations related to substance abuse were 10.53 and 1.01 per 1,000 homeless and nonhomeless youths, respectively. Homeless patients were more likely to utilize and revisit the ICU, be hospitalized or readmitted, incur higher costs, and have longer LOS than nonhomeless youths (all p<0.01).

conclusionsThe hospitalization and ED visit rates related to substance abuse were 10 and two times higher among homeless youths compared with nonhomeless youths, respectively. Detailed observation is needed to clarify whether homeless youths receive high-quality care for substance abuse when necessary.

Indexed as

Homeless YouthIll-Housed PersonsSubstance-Related DisordersAdolescentAdultChildEmergency Service, HospitalHumansNew YorkPatient Acceptance of Health CareUnited StatesYoung AdultAlcohol and drug abuseHealth care utilizationHomelessnessYoung adultsYouths

Identifiers

PMID33789461
PMCPMC8106548
OpenAlexW3145432258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.